Literature DB >> 29743125

Significant spike in excess mortality in England in winter 2014/15 - influenza the likely culprit.

R G Pebody1, H K Green1, F Warburton1, M Sinnathamby1, J Ellis1, K Mølbak2, J Nielsen2, S de Lusignan3, N Andrews1.   

Abstract

Significant increases in excess all-cause mortality, particularly in the elderly, were observed during the winter of 2014/15 in England. With influenza A(H3N2) the dominant circulating influenza A subtype, this paper determines the contribution of influenza to this excess controlling for weather. A standardised multivariable Poisson regression model was employed with weekly all-cause deaths the dependent variable for the period 2008-2015. Adjusting for extreme temperature, a total of 26 542 (95% CI 25 301-27 804) deaths in 65+ and 1942 (95% CI 1834-2052) in 15-64-year-olds were associated with influenza from week 40, 2014 to week 20, 2015. This is compatible with the circulation of influenza A(H3N2). It is the largest estimated number of influenza-related deaths in England since prior to 2008/09. The findings highlight the potential health impact of influenza and the important role of the annual influenza vaccination programme that is required to protect the population including the elderly, who are vulnerable to a severe outcome.

Entities:  

Keywords:  Influenza A; vaccination (immunization)

Mesh:

Year:  2018        PMID: 29743125      PMCID: PMC9134289          DOI: 10.1017/S0950268818001152

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  29 in total

1.  Influenza surveillance in England and Wales: October 1999 to May 2000.

Authors:  N L Goddard; C A Joseph; M Zambon; M Nunn; D Fleming; J M Watson
Journal:  Commun Dis Public Health       Date:  2000-12

2.  Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons.

Authors:  Liselotte van Asten; Cees van den Wijngaard; Wilfrid van Pelt; Jan van de Kassteele; Adam Meijer; Wim van der Hoek; Mirjam Kretzschmar; Marion Koopmans
Journal:  J Infect Dis       Date:  2012-06-21       Impact factor: 5.226

3.  [Excess mortality associated with influenza in Spain in winter 2012].

Authors:  Inmaculada León-Gómez; Concepción Delgado-Sanz; Silvia Jiménez-Jorge; Víctor Flores; Fernando Simón; Diana Gómez-Barroso; Amparo Larrauri; Salvador de Mateo Ontañón
Journal:  Gac Sanit       Date:  2015-03-12       Impact factor: 2.139

4.  Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study.

Authors:  Fatimah S Dawood; A Danielle Iuliano; Carrie Reed; Martin I Meltzer; David K Shay; Po-Yung Cheng; Don Bandaranayake; Robert F Breiman; W Abdullah Brooks; Philippe Buchy; Daniel R Feikin; Karen B Fowler; Aubree Gordon; Nguyen Tran Hien; Peter Horby; Q Sue Huang; Mark A Katz; Anand Krishnan; Renu Lal; Joel M Montgomery; Kåre Mølbak; Richard Pebody; Anne M Presanis; Hugo Razuri; Anneke Steens; Yeny O Tinoco; Jacco Wallinga; Hongjie Yu; Sirenda Vong; Joseph Bresee; Marc-Alain Widdowson
Journal:  Lancet Infect Dis       Date:  2012-06-26       Impact factor: 25.071

5.  Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice.

Authors:  Pia Hardelid; Douglas M Fleming; Nick Andrews; Michele Barley; Hayley Durnall; Punam Mangtani; Richard Pebody
Journal:  Vaccine       Date:  2011-12-16       Impact factor: 3.641

Review 6.  Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis.

Authors:  Krista Wilkinson; Yichun Wei; Andrea Szwajcer; Rasheda Rabbani; Ryan Zarychanski; Ahmed M Abou-Setta; Salaheddin M Mahmud
Journal:  Vaccine       Date:  2017-04-18       Impact factor: 3.641

7.  Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study.

Authors:  Marc Baguelin; Stefan Flasche; Anton Camacho; Nikolaos Demiris; Elizabeth Miller; W John Edmunds
Journal:  PLoS Med       Date:  2013-10-08       Impact factor: 11.069

8.  Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999-2010.

Authors:  P Hardelid; R Pebody; N Andrews
Journal:  Influenza Other Respir Viruses       Date:  2012-03-09       Impact factor: 4.380

9.  Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results.

Authors:  Richard Pebody; Fiona Warburton; Nick Andrews; Joanna Ellis; Beatrix von Wissmann; Chris Robertson; Ivelina Yonova; Simon Cottrell; Naomh Gallagher; Helen Green; Catherine Thompson; Monica Galiano; Diogo Marques; Rory Gunson; Arlene Reynolds; Catherine Moore; David Mullett; Sameera Pathirannehelage; Matthew Donati; Jillian Johnston; Simon de Lusignan; Jim McMenamin; Maria Zambon
Journal:  Euro Surveill       Date:  2015

10.  Pooling European all-cause mortality: methodology and findings for the seasons 2008/2009 to 2010/2011.

Authors:  J Nielsen; A Mazick; N Andrews; M Detsis; T M Fenech; V M Flores; A Foulliet; B Gergonne; H K Green; C Junker; B Nunes; J O'Donnell; A Oza; A Paldy; R Pebody; A Reynolds; T Sideroglou; B E Snijders; F Simon-Soria; H Uphoff; L VAN Asten; M J Virtanen; F Wuillaume; K Mølbak
Journal:  Epidemiol Infect       Date:  2012-11-27       Impact factor: 4.434

View more
  7 in total

1.  All-cause excess mortality observed by age group and regions in the first wave of the COVID-19 pandemic in England.

Authors:  Mary A Sinnathamby; Heather Whitaker; Laura Coughlan; Jamie Lopez Bernal; Mary Ramsay; Nick Andrews
Journal:  Euro Surveill       Date:  2020-07

Review 2.  Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing.

Authors:  Sankarasubramanian Rajaram; Constantina Boikos; Daniele K Gelone; Ashesh Gandhi
Journal:  Ther Adv Vaccines Immunother       Date:  2020-02-22

3.  Spatio-temporal model to estimate life expectancy and to detect unusual trends at the local authority level in England.

Authors:  Areti Boulieri; Marta Blangiardo
Journal:  BMJ Open       Date:  2020-11-12       Impact factor: 2.692

4.  How have changes in death by cause and age group contributed to the recent stalling of life expectancy gains in Scotland? Comparative decomposition analysis of mortality data, 2000-2002 to 2015-2017.

Authors:  Julie Ramsay; Jon Minton; Colin Fischbacher; Lynda Fenton; Maria Kaye-Bardgett; Grant M A Wyper; Elizabeth Richardson; Gerry McCartney
Journal:  BMJ Open       Date:  2020-10-07       Impact factor: 2.692

5.  Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-CoV-2 status in England.

Authors:  Mark Joy; Fd Richard Hobbs; Jamie Lopez Bernal; Julian Sherlock; Gayatri Amirthalingam; Dylan McGagh; Oluwafunmi Akinyemi; Rachel Byford; Gavin Dabrera; Jienchi Dorward; Joanna Ellis; Filipa Ferreira; Nicholas Jones; Jason Oke; Cecilia Okusi; Brian D Nicholson; Mary Ramsay; James P Sheppard; Mary Sinnathamby; Maria Zambon; Gary Howsam; John Williams; Simon de Lusignan
Journal:  Br J Gen Pract       Date:  2020-11-26       Impact factor: 5.386

6.  Recent adverse mortality trends in Scotland: comparison with other high-income countries.

Authors:  Lynda Fenton; Jon Minton; Julie Ramsay; Maria Kaye-Bardgett; Colin Fischbacher; Grant M A Wyper; Gerry McCartney
Journal:  BMJ Open       Date:  2019-10-31       Impact factor: 2.692

7.  Household presentation of influenza and acute respiratory illnesses to a primary care sentinel network: retrospective database studies (2013-2018).

Authors:  Simon de Lusignan; Julian Sherlock; Oluwafunmi Akinyemi; Richard Pebody; Alex Elliot; Rachel Byford; Ivelina Yonova; Maria Zambon; Mark Joy
Journal:  BMC Public Health       Date:  2020-11-20       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.